Brittany Schock
Brittany is a senior managed care pharmacist with the Milwaukee office of Milliman. She joined the firm in 2023.
Experience
Brittany has over 10 years of experience in the specialty of managed care pharmacy. She has payor experience in the government sector, with extensive direct Medicaid experience. Brittany has expertise in formulary preferred drug list management, value based and supplemental rebate contracting, pharmacy operations, PBM and pharmacy point of sale systems, policy and legislation, and the pharmaceutical pipeline including high-cost, specialty medications.
Brittany supports payers, health plans and Medicaid programs to understand the clinical and financial aspects of policy, formulary, and coverage decisions. Specifically, Brittany devotes a significant portion of her time assessing and forecasting the landscape of emerging new cell and gene therapies and helps clients better understand opportunities to improve health care spend and clinical outcomes.
Prior to joining Milliman, Brittany completed a post graduate year one (PGY-1) managed care pharmacy residency with a government sponsored health plan specializing in Medicare and Medicaid. She also has experience working as the Preferred Drug List and Clinical Strategy Pharmacist for a state Medicaid program in the executive branch of government. There she supported a variety of work, focused on managing drug spend, pharmacy trend analysis, improving value and clinical outcomes, and ensuring evidence-based patient access to medications.
- Co-author, Exploring the provider landscape in Sickle Cell Disease through a gene therapy lens. Milliman MedInsight White Paper, November 2024.
- Co-author, How will Medicaid pay for cell and gene therapies? Milliman White Paper, November 2024.
- GLP-1 agonists in Medicaid: Utilization, Growth and Management. Medicaid State Client Forum, July 2024.
- Medicaid: Gene Therapies, GLP-1 Agonists. Milliman Client Webinar, March 2024.
- GLP-1 agonists in Medicaid: Utilization, Growth and Management. Society of Actuaries Medicaid Meeting, February 2024.
- Co-author, GLP-1 agonists in Medicaid: Utilization, growth and management. Milliman White Paper, January 2024.
- Co-author, Average Manufacturer Price cap removal: Implications for state Medicaid programs. Milliman White Paper, November 2023.
Professional Designations
- Licensed Pharmacist, Colorado
- Licensed Pharmacist, Florida
Education
- ASHP Accredited PGY-1 Managed Care Residency
- PharmD, University of Colorado
- BA, University of Colorado
- Member, Academy of Managed Care Pharmacy
Publications